Facts to review
Hiv medicines reduces the spreading of hiv infection
HIV makes us equal, the HIV virus does not discriminate
Once you get HIV, you have it for life. No total cure exists.
AIDS is not a disease, it is a syndrome
What hiv medicines do to your body
HIV tests - are they reliable?
You can't get infected by hiv by kissing
200 pages that questions hiv/aids
How to cure what we call hiv/aids
Poppers, Narcotics, Crystal Meth causes immunodeficiency
Preserving Health and Prolonging Life for People with HIV
This is what official hiv/aids organisations claim they do
(www.nih.gov) "Preserving Health and Prolonging Life for People with HIV"
"Since the advent of combination antiretroviral therapy to treat HIV, people infected with the virus have been living longer and experiencing fewer of the medical conditions directly attributable to HIV infection and AIDS."
Antiretroviral medicines Preserving Health and Prolonging Life -reality check
The list of deadly side effects goes on and on. Learn the link -hiv medications - side effects - death.
How can these chemicals be good for any person? would you give this to your own child? If you have a positive hiv diagnosis, what rights do you have for proper medical treatment like other people get?
Commonly used medical terms of side effects in package inserts for HIV medications.
Intracranial hemorrhage means internal bleeding inside your cranium/head.
Hepatotoxicity means liver damage.
Lactic acidosis means acidic blood, the ph levels of the blood is changed. This is extremely serious when the blood pH value must remain strictly within specific levels for the body to function.
Renal Impairment means kidney damage/failure.
Subcutaneous Tissue Disorders means a derangement or abnormality of function beneath the skin.
intracranial /in·tra·cra·ni·al/ (-kra´ne-al) -within the cranium.
hemorrhage /hem·or·rhage/ (hem´ah-rij) the escape of blood from the vessels; bleeding.hemorrhag´ic
hepatotoxicity [hep'?totoksis'ite] Etymology: Gk, hepar + toxikon, poison the tendency of an agent, usually a drug or alcohol, to have a destructive effect on the liver.
lactic acidosis /ac·i·do·sis/ (as?i-do´sis) the accumulation of acid and hydrogen ions or depletion of the alkaline reserve (bicarbonate content) in the blood and body tissues, decreasing the pH.
steatosis /ste·a·to·sis/ (ste?ah-to´sis) fatty change. See fatty degeneration.
Convulsions Also termed seizures; a sudden violent contraction of a group of muscles.
renal impairmentrenal failure (redirected from Renal impairment) failure /fail·ure/ (fal´yer) inability to perform or to function properly.
renal /re·nal/ (re´n'l) pertaining to the kidney.
Subcutaneous /sub·cu·ta·ne·ous/ (sub?ku-ta´ne-us) beneath the skin.
disorder /dis·or·der/ (dis-or´der) a derangement or abnormality of function; a morbid physical or mental state.
(Atripla package insert)
Side effects: Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, New Onset or Worsening Renal Impairment, Reproductive Risk Potential, Decrease in Bone Mineral Density
Serious psychiatric symptoms, Nervous System Symptoms, Rash, Hepatotoxicity, Convulsions, Fat Redistribution, Headache, Anxiety, Depression, Insomnia, Dizziness, Skin and Subcutaneous Tissue Disorders, Sinusitis
Upper respiratory tract infections, Nasopharyngitis, Fatigue, Diarrhea, Nausea, Vomiting.
"ATRIPLA does not cure HIV-1 infection or AIDS and you may continue to experience illnesses associated with HIV-1 infection, including opportunistic infections."
(Aptivus package insert) WARNING: HEPATOTOXICITY and INTRACRANIAL
HEMORRHAGE Clinical hepatitis and hepatic decompensation including some
"Fatal and non-fatal intra cranial hemorrhage
What are the possible side effects of APTIVUS?
APTIVUS may cause serious side effects, including: liver problems, including liver failure and death.
Bleeding in the brain.
This has occurred in patients treated with APTIVUS in clinical trials and can lead to permanent
disability or death. Many of the patients
experiencing bleeding in the brain had other medical conditions or were receiving other
medications that may have caused or added to bleeding in the brain. Patients with hemophilia or another medical condition that
increases the chance of bleeding, or patients taking medicines that may cause bleeding may have an increased chance of
bleeding in the brain.
Rash, including flat or raised rashes or sensitivity to the sun, have been reported in approximately 10% of subjects
receiving APTIVUS. Some patients who developed rash also had one or more of the following symptoms: joint pain or stiffness,
throat tightness, generalized itching, muscle aches, fever, redness, blisters, or peeling of the skin. Women taking birth control
pills may get a skin rash. If you develop any of these symptoms, stop using APTIVUS and call your healthcare professional right away.
The most common side effects of APTIVUS include diarrhea, nausea, fever, vomiting, tiredness, headache, and stomach pain. Rash
was seen more frequently in children.
Do not give APTIVUS to other people, even if they have the same condition you have. It may harm them.
APTIVUS does not cure HIV infection or AIDS and you may continue to experience illnesses associated with HIV-1 infection,
including opportunistic infections."
COMPLERA. (emtricitabine/rilpivirine/tenofovir disoproxil fumarate)
(COMPLERA package insert)
WARNINGS: LACTIC ACIDOSIS/SEVERE HEPATOMEGALY
WITH STEATOSIS and POST TREATMENT ACUTE
EXACERBATION OF HEPATITIS
Lactic acidosis and severe hepatomegaly with steatosis,
including fatal cases, have been reported with the use of
nucleoside analogs, including tenofovir disoproxil
fumarate, a component of COMPLERA
What are the possible side effects of COMPLERA?
New or worse kidney problems, depression or mood changes, feeling sad or hopeless, feeling anxious or restless, have thoughts of hurting yourself (suicide)
Bone problems, bone pain, softening or thinning (which may lead to fractures), changes in body fat, These changes may include increased amount of fat in the upper back and neck (“buffalo hump”), breast, and around the main part of your body
(trunk). Loss of fat from the legs, arms and face may also happen. The cause and long term health effect of these conditions are not known.
Changes in your immune system
(Immune Reconstitution Syndrome)
can happen when you start taking HIV medicine
s. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. Tell your healthcare provider if you start having new symptoms after starting
your HIV medicine.
The most common side effects of COMPLERA include: trouble sleeping (insomnia), abnormal dreams, headache, dizziness, diarrhea, nausea, rash, tiredness, depression
Additional common side effects include: vomiting, stomach pain or discomfort, skin discoloration (small spots or freckles), pain.
Do not give COMPLERA to other people, even if they have the same symptoms you have. It may harm them.
COMPLERA does not cure HIV infections or AIDS.
(CRIXIVAN package insert)
What are the possible side effects of CRIXIVAN?
Some patients treated with CRIXIVAN have had rapid breakdown of red blood cells (hemolytic anemia)
which in some cases was severe or resulted in death.
Some patients treated with CRIXIVAN have had liver problems including liver failure and death. Some
patients had other illnesses or were taking other drugs. It is uncertain if CRIXIVAN caused these liverproblems. (My comment: then why even mention it?)
Side effects occurring in 2% or more of patients
included: abdominal pain, fatigue or weakness, low red blood cell count, flank pain, painful urination, feeling unwell, nausea, upset stomach, diarrhea, vomiting, acid regurgitation, increased or decreased appetite,
back pain, headache, dizziness, taste changes, rash, itchy skin, yellowing of the skin and/or eyes, upper respiratory infection, dry skin, and sore throat.
Other side effects reported since CRIXIVAN has been marketed include: allergic reactions; severe skin reactions; yellowing of the skin and/or eyes; heart
problems including heart attack; stroke; abdominal swelling; indigestion; inflammati
on of the kidneys; decreased kidney function; inflammation of the pancreas; joint pain; depression; itching; hives; change
in skin color; hair loss; ingrown toenails with or without infection; crystals in the urine; painful urination; numbness of the mouth and increased cholesterol.
changes in body fat – combination antiretroviral therapy may cause changes in your body shape. This is due to changes in fat distribution (such as loss of fat from legs, arms and face, increased fat in your belly or other internal organs, breast enlargement and fatty lumps on the back of the neck (‘buffalo hump’)). The cause and long-term effects of these conditions are not known. Issued 2013.
CRIXIVAN does not cure HIV infection or AIDS and you may continue to experience illnesses associated with HIV-1 infection, including opportunistic infections.
(EDURANT package insert)
Warnings and PrecaUtions
Depressive Disorders: Severe depressive disorders have been reported
The adverse reaction depressive disorders (depressed mood, depression,
dysphoria, major depression, mood altered, negative thoughts, suicide attempt,
suicidal ideation) has been reported with EDURANT.
Hepatotoxicy: A few cases of hepatotoxicity have occurred in patients with no pre-existing hepatic disease.
Enlargement (buffalo hump), peripheral wasting, facial wasting, breast
enlargement, and “cushingoid appearance” have been observed in patients
receiving antiretroviral therapy. The mechanism and long-term consequences of
these events are currently unknown. A causal relationship has not been
immune reconstitution syndromeImmune
combination antiretroviral therapy, including EDURANT. During the initial phase
of combination antiretroviral treatment, patients whose immune system responds
may develop an inflammatory response to indolent or residual opportunistic
infections (such as Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia or tuberculosis), which may necessitate
further evaluation and treatment. Autoimmune disorders (such as Graves’ disease, polymyositis, and Guillain-Barré syndrome) have also been reported to occur in the setting of immune reconstitution;
(EMTRIVA package insert)
WARNINGS LACTIC ACIDOSIS AND SEVERE HEPATOMEGALY WITH STEATOSIS,
INCLUDING FATAL CASES, HAVE BEEN REPORTED WITH THE USE OF NUCLEOSIDE ANALOGS ALONE OR IN COMBINATION WITH OTHER ANTIRETROVIRALS (SEE WARNINGS)
EMTRIVA may cause the following serious side effects:
lactic acidosis (buildup of an acid in the blood). Lactic acidosis can be a
medical emergency and may need to be treated in the hospital.
serious liver problems (hepatotoxicity), with liver enlargement (hepatomegaly) and fat in the liver (steatosis).
“flare-ups” of Hepatitis B Virus infection, in which the disease suddenly returns in a worse way than before, can occur if you stop taking EMTRIVA.
Other side effects with EMTRIVA when used with other anti-HIV medicines Include:
Changes in body fat have been seen in some patients taking EMTRIVA and
other anti-HIV medicines. These changes
may include increased amount of fat in the upper back and neck (“buffalo hump”), breast, and around the main part ofyour body (trunk). Loss of fat from
the legs, arms and face may also happen. The cause and long term health effects of these conditions are not known at this time.
This list of side effects is not complete
EMTRIVA does not cure HIV infection or AIDS."
(Epivir package insert)
WARNING LACTIC ACIDOSIS AND SEVERE HEPATOMEGALY WITH STEATOSIS, INCLUDING
FATAL CASES, HAVE BEEN REPORTED WITH THE USE OF NUCLEOSIDE
ANALOGUES ALONE OR IN COMBINATION, INCLUDING LAMIVUDINE AND OTHER ANTIRETROVIRALS
Fat Redistribution: Redistribution/accumulation of body fat including central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, and
“cushingoid appearance” have been observed in patients receiving antiretroviral therapy. The mechanism and long-term consequences of these events are currently unknown. A causal relationship has not been established.
The most common adverse events in both treatment groups were nausea, dizziness, fatigue and/or malaise, headache, dreams, insomnia and other sleep disorders, and skin rash.
EPIVIR is not a cure for HIV infection and patients may continue to experience illnesses associated with HIV infection, including opportunistic infections.
EPZICOM (abacavir sulfate and lamivudine)
(EPZICOM package insert, epzicom.com) EPZICOM contains abacavir sulfate, which has been associated with serious and sometimes fatal hypersensitivity reactions. (See full Important Safety Information.)
Following a hypersensitivity reaction to abacavir, NEVER restart EPZICOM or any other abacavir-containing product because more severe symptoms can occur within hours and may include life-threatening hypotension and death
EPZICOM contains abacavir sulfate, which has been associated with serious and sometimes fatal hypersensitivity reactions. Hypersensitivity to abacavir is a multi-organ clinical syndrome usually characterized by a sign or symptom in 2 or more of the following groups: (1) fever, (2) rash, (3) gastrointestinal (including nausea, vomiting, diarrhea, or abdominal pain), (4) constitutional (including generalized malaise, fatigue, or achiness), and (5) respiratory (including dyspnea, cough, or pharyngitis).
EPZICOM does not cure HIV infection or AIDS. We do not know if EPZICOM will help you live longer or have fewer of the medical problems that people get with HIV or AIDS.
(FUZEON package insert, fuzeon.com) What are the possible side effects of FUZEON?
FUZEON can cause serious allergic reactions. Symptoms of a serious allergic reaction with FUZEON can include: trouble breathing, fever with vomiting and a skin rash, blood in your urine, swelling of your feet
Patients taking FUZEON with other HIV medicines may get bacterial pneumonia more often than patients not receiving FUZEON. Three patients in the clinical trials who took FUZEON died of pneumonia.
The following side effects were seen more often in patients using FUZEON with their other anti-HIV medicines than in patients not using FUZEON with their other anti-HIV medicines:
pain and numbness in feet or legs, loss of sleep, depression, decreased appetite, sinus problems, enlarged lymph nodes, weight decrease, weakness or loss of strength, muscle pain, constipation, pancreas problems
FUZEON is not a cure for HIV-1 infection and patients may continue to contract illnesses associated with HIV-1 infection.
Review: Stevens-johnson syndrome in Fuzeon. On Oct, 21, 2013: 2,259 people reported to have side effects when taking Fuzeon. Among them, 20 people (0.89%) have Stevens-johnson Syndrome.
(INTELENCE package insert)
INTELENCE does not cure HIV infection or AIDS.
WARNINGS AND PRECAUTIONS Severe, potentially life threatening and fatal skin reactions have been reported."
INVIRASE (saquinavir mesylate)
(INVIRASE package insert) INVIRASE does not cure HIV, and it does not prevent you from getting other illness from advanced HIV
(ISENTRESS package insert)
ISENTRESS does not cure HIV infection or AIDS.
People taking ISENTRESS may still develop
infections or other conditions associated with HIV
(LEXIVA package insert)
LEXIVA does not: cure HIV infection or AIDS. We do not know if LEXIVA will help you live longer or have fewer of the medical problems (opportunistic infections) that people get with HIV or AIDS However, LEXIVA does not work in all patients with HIV."
(LEXIVA package insert)
KALETRA does not cure HIV infection or AIDS. People taking KALETRA may still get opportunistic infections or
other conditions that happen with HIV infection."
(NORVIR package insert)
NORVIR does not cure HIV infection or AIDS. The long-term effects of NORVIR
are not known at this time. People taking NORVIR may still get opportunistic
infections or other conditions that happen with HIV infection."
(PREZISTA package insert)
PREZISTA does not cure HIV infection or AIDS. People taking PREZISTA may still develop infections or other conditions associated with HIV infection,
Do not have any kind of sex without protection.
WARNINGS some fatalities, have been reported."
RESCRIPTOR (delavirdine mesylate)
PRECAUTIONS Skin Rash: Severe rash including rare cases of erythema multiforme and Stevens-Johnson
syndrome have been reported in patients receiving Rescriptor.
Medical events occurring in less than 2% of patients
receiving RESCRIPTOR (in
combination treatment) in all phase II and III studies, considered possibly related to
treatment, and of at least ACTG grade 2 in intensity are listed below by body system.
Body as a Whole:
Abdominal cramps, abdominal distention, abdominal pain (generalized
or localized), allergic reaction, asthenia, back pain, chest pain, chills, edema (generalized
or localized), epidermal cyst, fever, flank pain, flu syndrome, lethargy, lip edema, malaise,
neck rigidity, pain (generalized or localized), sebaceous cyst, trauma, and upper
Bradycardia, migraine, pallor, palpitation, postural hypotension,
syncope, tachycardia, and vasodilation.
Anorexia, aphthous stomatitis, bloody stool, colitis, constipation,
decreased appetite, diarrhea (Clostridium difficile), diverticulitis, duodenitis, dry mouth,
dyspepsia, dysphagia, enteritis, esophagitis, fecal incontinence, flatulence, gagging,
gastritis, gastroesophageal reflux, gastrointestinal bleeding, gastrointestinal disorder,
gingivitis, gum hemorrhage, increased appetite, increased saliva, increased thirst, mouth
ulcer, nonspecific hepatitis, pancreatitis, rectal disorder, sialadenitis, stomatitis, and tongue
edema or ulceration.
Hemic and Lymphatic System:
Anemia, bruise, ecchymosis, eosinophilia, granulocytosis,
neutropenia, pancytopenia, petechia, prolonged partial thromboplastin time, purpura,
spleen disorder, and thrombocytopenia.
Metabolic and Nutritional Disorders:
Alcohol intolerance, bilirubinemia, hyperkalemia,
hyperuricemia, hypocalcemia, hyponatremia, hypophosphatemia, increased gamma
glutamyl transpeptidase, increased lipase, increased serum alkaline phosphatase, increased serum amylase, increased serum creatine phosphokinase, increased serum creatinine,
peripheral edema, and weight increase or decrease.
Arthralgia or arthritis of single and multiple joints, bone disorder,
bone pain, leg cramps, muscular weakness, myalgia, tendon disorder, tenosynovitis, and
Abnormal coordination, agitation, amnesia, anxiety, change in dreams,
cognitive impairment, confusion, decreased libido, depressive symptoms, disorientation,
dizziness, emotional lability, hallucination, hyperesthesia, hyperreflexia, hypesthesia,
impaired concentration, insomnia, manic symptoms, muscle cramp, nervousness,
neuropathy, nightmares, nystagmus, paralysis, paranoid symptoms, paresthesia,
restlessness, somnolence, tingling, tremor, vertigo, and weakness.
Bronchitis, chest congestion, cough, dyspnea, epistaxis, laryngismus,
pharyngitis, rhinitis, and sinusitis.
Skin and Appendages:
Angioedema, dermal leukocytoclastic vasculitis, dermatitis,
desquamation, diaphoresis, dry skin, erythema, erythema multiforme, folliculitis, fungal
dermatitis, hair loss, nail disorder, petechial rash, seborrhea, skin disorder, skin nodule,
Stevens-Johnson syndrome, urticaria, and vesiculobullous rash.
Blepharitis, conjunctivitis, diplopia, dry eyes, ear pain, photophobia, taste
perversion, and tinnitus.
Breast enlargement, calculi of the kidney, epididymitis, hematuria,
hemospermia, impotence, kidney pain, metrorrhagia, nocturia, polyuria, proteinuria, and
Toxicities among various organs and organ systems in rats, mice, rabbits, dogs,
and monkeys were observed following the administration of delavirdine.
(RESCRIPTOR package insert) "Patients should be advised that the long-term effects of treatment with RESCRIPTOR are unknown at this time.
(RETROVIR package insert)
Patients should be told that the long-term effects of RETROVIR are unknown at this time. 05/08/2006
Original Approval or Tentative Approval Date March 19, 1987"
(REYATAZ package insert)
REYATAZ does not cure HIV infection or AIDS.
At present there is no cure for HIV infection. People taking REYATAZ may still get opportunistic infections or other conditions that happen with HIV infection."
(SELZENTRY package insert)
SELZENTRY will not cure HIV infection.
People taking SELZENTRY may still develop infections, including opportunistic infections or other conditions that happen with HIV infection.
It is very important that you stay under the care of your doctor during treatment with SELZENTRY.
The long-term effects of SELZENTRY are not known at this time. Issued August 2007.
STRIBILD (elvitegravir, cobicistat, emtricitabine, tenofovir, disoproxil fumarate)
(STRIBILD package insert) "Do not give STRIBILD to other people, even if they have the same symptoms you have. It may harm them.
STRIBILD does not cure HIV-1 infections or AIDS.
(SUSTIVA package insert)
SUSTIVA does not cure HIV or AIDS. People taking SUSTIVA may still develop other
infections and complications.
Some patients have thoughts of suicide and a few have actually
Some patients taking SUSTIVA have experienced serious liver problems including liver failure resulting in transplantation or death."
TRUVADA (emtricitabine/tenofovir disoproxil fumarate)
Side effects: Lactic acidosis and severe hepatomegaly with steatosis,including fatal cases, have been reported, Severe Acute Exacerbations of hepatitis B, New Onset or Worsening Renal Impairment, Decreases in Bone Mineral Density, diarrhea, nausea, fatigue,
headache, dizziness, depression, insomnia, abnormal dreams, and rash, Skin discoloration, manifested by hyperpigmentation on the palms and/or soles, Upper respiratory tract infections, Back pain, Anxiety.
(VIDEX package insert)
VIDEX will not cure your HIV infection. At present there is no cure for HIV infection.
Even while taking VIDEX, you may continue to have HIV-related illnesses, including
infections with other disease- producing organisms."
(VIRACEPT package insert)
(VIRAMUNE package insert)
VIRAMUNE does not cure HIV or AIDS, and it is not known if it will help you live longer with HIV. People taking VIRAMUNE may still get infections common in people with HIV (opportunistic infections)."
VIREAD (tenofovir disoproxil fumarate)
(VIREAD package insert)
VIREAD does not cure HIV infection or AIDS. People taking VIREAD may still develop infections or other conditions associated with HIV infection."
(ZERIT package insert)
ZERIT (stavudine) will not cure your HIV infection. At present there is no cure for HIV
infection. Even while taking ZERIT, you may continue to have HIV-related illnesses, including
infections caused by other disease-producing organisms."
(ZIAGEN package insert) "ZIAGEN does not cure HIV infection or AIDS.
It is not known if ZIAGEN will help you live longer or have fewer of the medical problems that people get with HIV or AIDS."
"The risk of an asymptomatic
person with a repeatedly reactive serum developing AIDS or an AIDS-related condition is not known, as the course of HIV infection may vary among individual patients and may be altered by antiretroviral therapy.
However, in a prospective study, AIDS developed in
51% of homosexual men after 10 years of infection."